TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.74
+1.61%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.09
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.02
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -342.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $17
- PT range
- $10 – $24
- Analysts
- 2
1 Buy0 Hold1 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.02 | -$0.20 | Miss -900.00% | — |
| May 11, 2026 | -$0.02 | -$0.03 | Miss -50.00% | — |
| Mar 31, 2026 | -$0.05 | -$0.09 | Miss -76.47% | — |
| Nov 13, 2025 | — | -$0.07 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026